Natco Pharma Share Price Target 2024, 2025, 2027, 2030

In this blog about Natco Pharma Share Price Target we are trying to give investors a unique idea. Before investing in any share, you should know each & every detail about the share in times of huge ups and downs in every share market. We did the research and took advice from experts to make this blog about the company’s growth, performance, etc.

Natco Pharma Share Price Target is a trading share in the share market. In this article, we will discuss the company’s financial growth, business policy, shareholding pattern, and forecast share price yearly. We use expert data and analysis to understand the Natco Pharma Share Price Target 2024 to 2030.

What Is Natco Pharma Limited?

Natco Pharma is an Indian multinational pharmaceutical company which was established in the year 1981. The headquarters of the company is situated in Hyderabad. The company mainly manufactures agrochemical and active pharmaceutical products. The company mainly manufactures medicine for the treatment of oncology, cardiology, diabetology, and other pharma specialty drugs.

Fundamental Analysis Of Natco Pharma Limited

Company Name	Natco Pharma Limited
Market Cap	₹26,215.98 Crore
P/B	4.5
Face Value	₹2
Book Value	₹347.98
52 Week High	₹1,540.12
52 Week Low	₹724.20
DIV. YIELD	0.67%

Financial Data Analysis Of Natco Pharma Limited

We need a basic idea about the company’s PE ratio, return on assets, current ratio, and return on equity. In the section below, we discuss the performance of the company. Natco Pharma Share Price Target also depends on the ratio described below.

PE Ratio	Return On Assets (ROA)	Operating Profit Margin	Return On Equity (ROE)
17.23	0.65%	34.98%	14.38%

Dividend History Of Natco Pharma Share

The last few year’s dividend history of Natco Pharma Share is described below.

• For the year 2024, the interim dividend history is ₹3.0000 per share.
• For the year 2023, the interim dividend history was ₹1.2500 per share.
• For the year 2022, the interim dividend history was ₹0.75000 per share.
• For the year 2021, the interim dividend history was ₹0.5000 per share.
• For the year 2020, the interim dividend history was ₹3.0000 per share.

Also Read – Gland Pharma Share Price Target

Today’s Price Of Natco Pharma Share

Natco Pharma Share is under both the Indian Stock Exchange BSE (Bombay Stock Exchange) and NSE (National Stock Exchange). Today (19-08-2024) the Natco Pharma Share Price rate is ₹1,470.20 at 9:55 pm which was open at ₹1,466.05 and the highest rate was ₹1,474.65 until now.

History Of Natco Pharma Share Price Target From The Year 2024 to 2040

Natco Pharma Share has been growing upward till the last 1 year. The last 6 months’ share growth was +406.50 (38.285%), the last 1 years share growth was +612.90 (71.055), the last 5 years share growth was +928.25 (169.53%) and the maximum share growth was +1,467.46 (41,411.30%).

Natco Pharma Share Price return percentage was 48.12% in the last 3 months, the last 1 year’s share price return percentage was 70.10%, and the last 3 years’ share price return percentage was 52.39%. Natco Pharma Share always gives good returns to investors. If anyone wants to invest in the share it will be profitable on a long-term basis. Let’s have a look at Natco Pharma Share Price Target from 2024 to 2040.

Natco Pharma Share Price Target 2024

Natco Pharma Limited is a research-led pharmaceutical company that is involved in the manufacturing and marketing of finished dosage formulations and manufacturing of active pharmaceutical ingredients for domestic and as well as international markets. The company distributes its products in different 50 countries. The company mainly focused on niche therapeutic areas. The company’s API products are mainly sold in international markets like Brazil, Europe, and USA.

Year	Natco Pharma Share Price Target 2024
1st Price Target	₹1,258.98
2nd Price Target	₹1,585.23

The Profit growth of Natco Pharma was -1.85% in the last 5 years which increased to 10.36% in the last 3 years and in the last 1 year the percentage became 359.02%. The operating profit amount was ₹504.12 Crore in June 2023 which increased to ₹764 in June 2024. If we look at Natco Pharma Share Price Target 2024 forecast the 1st Price Target is ₹1,258.98 and the 2nd Price Target is ₹1,585.23.

Natco Pharma Share Price Target 2025

Natco Pharma company has 6 Finished Dosage Formulation facilities, 2 API manufacturing facilities, 2 Crop Health Sciences Units, and 2 R&D Centres. One of the most important implementations of Natco Pharma in the pharmaceutical industry is the development of Generic Research. In the field of Generic research, the company uses innovative and cost-effective technology and innovated Nobel Drug Delivery System.

Year	Natco Pharma Share Price Target 2025
1st Price Target	₹1,612.10
2nd Price Target	₹1,825.36

The Sales Growth Percentage of the company was 2.39% in the last 5 years which increased to 9.56% in the last 3 years and in the last 1 year it increased to 33.01%. The Net Sales amount of the company was ₹1,049.12 Crore in June 2023 which increased to ₹1,238.52 Crore in June 2024. If we look at Natco Pharma Share Price Target 2025 forecast the 1st Price Target is ₹1,612.10 and the 2nd Price Target is ₹1,825.36.

Natco Pharma Share Price Target 2027

Natco Pharma Company innovated new drugs in the Oncology department and spread them to the world. The company has a strong presence in Canada with 30+ new products under Oncology, anti-viral, cardiovascular, and CNS therapies. In the financial year 2022-23, the company earn ₹2,698 Million from Canada. For the research purpose, the R&D expenditure percentage was ₹2,268 Million in 2022, which decreased to ₹1,960 Million in 2023.

Year	Natco Pharma Share Price Target 2027
1st Price Target	₹2,212.74
2nd Price Target	₹2,488.01

The ROE percentage of Natco Pharma company was 11.9% in the last 5 years which decreased to 8.54% in the last 3 years and in the last 1 year increased to 14.35%. The ROCE percentage of the company was 13.8% in the last 5 years which decreased to 9.93% in the last 3 years and in the last 1 year, the amount increased to 16.54%. If we look at Natco Pharma Share Price Target 2027 forecast the 1st Price Target is ₹2,212.74 and the 2nd Price Target is ₹2,488.01.

Natco Pharma Share Price Target 2030

Glatiramer Acetate is a generic version of a complex of Natco Pharma Company which launched in the USA market this product company generated a huge amount of revenue. The Cardiology and Diabetology department of Natco Pharma company also launched many new products like Ticagrelor, Vidanat, and Dabigatran which have mainly been used during the time of COVID-19. The company also did business in Brazil in the year 2021-22 the earning revenue amount was ₹539 million.

Year	Natco Pharma Share Price Target 2030
1st Price Target	₹3,125.89
2nd Price Target	₹3,485.01

As Nacto Pharma spread its business outside of India also the FII investor percentage of the company increased to 17.20% which is a very good side for the company’s growth. The company is a very old company and has a good promotor holding capacity which is 50.10% which means many good investor wants to invest in the share. If we look at Natco Pharma Share Price Target 2030 forecast the 1st Price Target is ₹3,125.89 and the 2nd Price Target is ₹3,485.01.

Natco Pharma Share Price Target 2040

Natco Pharma company also works for Crop Health Sciences. Natco Pharma company has made pheromone-based biopesticide products like NATMATE PBW. In this sector, the company invested ₹1,930 mn in the financial year 2022-23.

Year	Natco Pharma Share Price Target 2040
1st Price Target	₹6,585.23
2nd Price Target	₹6,915.12

The total revenue of Natco Pharma Company was ₹2,438.56 Crore in March 2023 which increased to ₹3,745.85 Crore in March 2024. The total expenses amount of the company was ₹1,675.12 Crore in March 2023 which increased to ₹2,134.56 Crore in March 2024. If we look at Natco Pharma Share Price Target 2040 forecast the 1st Price Target is ₹6,585.23 and the 2nd Price Target is ₹6,915.12.

Peers Company Of Natco Pharma Limited

Company Name	Market Cap (Crore)
Aarti Drugs	₹5,185.39
Abbott India	₹61,325.42
Ajanta Pharma	₹38,763.73
Alembic Pharma	₹21,622.95

Some factors that may change the value of Natco Pharma Share

• Market Demand For Medicine
• Healthcare is like that type of sector which has never chances for lost demand.
• Especially with the COVID-19 situation every healthcare sector increases gradually.
• Strong Financial Condition
• Strong profit growth and sales growth of the company also encourage the investor’s confidence.
• The company has a good cost managment policy which increases the profit growth of the company.
• Strong Partnerships
• Natco Pharma Company has strong partnerships with many foreign countries company which have a good impact on the profit growth of the company.
• The company has secure government contracts for the manufacturing of medicine.

Also Read – Suven Pharma Share Price Target

Should I invest in Natco Pharma Share right now?

The last 3 months’ share price return percentage of Natco Pharma Limited was 48.12%. The last 6 months’ share growth was +406.50 (38.285%). The FII investor percentage in the share increased to 17.20%. The company also tries to improve its overall business in different ways which may affect the share also. Natco Pharma Share always gives good returns to investors. If anyone wants to invest in the share it will be profitable on a long-term basis. But before investing any share you should consult with any expertise.

Investors Types And Ratio Of Natco Pharma Limited

There are mainly four main Types of Investors in Natco Pharma Limited. The company’s growth also depended upon the ratio of investors who invested in the share.

Promoters Holding

Promoters Holding means how much capital is invested by company promoters (owner of the company) through overall capital. Natco Pharma Limited promoter holding capacity is 50.10%.

Public Holding

Public Investors are individuals who invest in the public market for profit in the future (large and small companies). Natco Pharma Limited public holding capacity is 24.80%.

FII

Foreign Institutional Investors are those big companies that invest in different countries company. Natco Pharma Limited FII is 17.20%.

DII

Domestic Institutional Investors (like Insurance, companies mutual funds) who invest in their own country. Natco Pharma Limited DII is 7.90%.

What Is the Future Growth of Natco Pharma Limited?

Positive Sides

• Natco Pharma company is one of the most important pioneers in the healthcare sector which uses modern technology for the manufacturing of drugs.
• Natco Pharma company started to manufacture all types of medicine which include cancer treatment.
• The company started to decrease its debt amount by 230.12 Crore.
• The company has a healthy interest cover ratio which is 90.63.
• The company has an efficient cash conversation cycle of 83.25 days.
• The company’s PEG ratio is 0.07.
• Natco Pharma company has fixed an Aim to expand its business more in the USA countries by the end of the year 2030 by establishing many branches and stores all over the country.
• In the COVID-19 situation, the company plays a vital role by supplying people with many helpful drugs.

Negative Sides

• The last 3 years revenue growth of Natco Pharma company is not running in a good position which is 9.52%.
• An increase in the cost Of medical equipment may affect the total expenditure of the company.
• The presence of many competitor companies may have some difficulties with grown-up individuals.\

Also Read – Cipla Share Price Target

FAQ

Conclusion

Hopefully, www.sharetargethub.com will help you gain some basic ideas about the Natco Pharma Share Price Target. By doing the research and taking advice from expertise we ensure that on a long-term basis, Natco Pharma Share Price Target may reach a very high position. Natco Pharma Company is related to the health care Sector. So the demand for this sector also increases which helps the share to gain profit in the future.

If you think this website will be helpful for you then you can share it. If you have any questions please let us know through the comment box we will try to reply to your questions and solve your problem. Thanks for visiting this website and thanks for being with us.

Disclaimer – We are not SEBI-registered advisors. A financial market is always risky to anyone. This website is only for training and educational purposes. So before investing, we are requested to discuss certified expertise. We will not be responsible for anyone’s profit or loss.